Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Daikaffil Chemicals India Ltd

DAIKAFFI
BSE
33.82
4.97%
Last Updated:
05 May '26, 1:28 PM
Company Overview
Alert
Watchlist
Note

Daikaffil Chemicals India Ltd

DAIKAFFI
BSE
33.82
4.97%
05 May '26, 1:28 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
20Cr
Close
Close Price
33.82
Industry
Industry
Chemicals - Organic
PE
Price To Earnings
PS
Price To Sales
1.32
Revenue
Revenue
15Cr
Rev Gr TTM
Revenue Growth TTM
339.71%
PAT Gr TTM
PAT Growth TTM
-26.48%
Peer Comparison
How does DAIKAFFI stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
DAIKAFFI
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
000000044461
Growth YoY
Revenue Growth YoY%
-100.0-100.0-100.0-58.0
Expenses
ExpensesCr
000010144372
Operating Profit
Operating ProfitCr
0000-10-1001-10
OPM
OPM%
-1.4-10.313.4-21.0-19.7
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
100000000000
PBT
PBTCr
-1000-10-1000-10
Tax
TaxCr
000000000000
PAT
PATCr
-1000-10-1000-10
Growth YoY
PAT Growth YoY%
-148.048.850.040.4-53.230.2-141.7-28.663.2240.0-131.05.6
NPM
NPM%
-10.3-8.810.8-22.2-23.1
EPS
EPS
-1.0-0.7-0.4-0.5-1.6-0.5-1.0-0.6-0.60.7-2.2-0.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
34272623171611810815
Growth
Revenue Growth%
3.2-20.4-3.7-13.7-26.2-6.7-27.5-28.5-92.2-100.0105.3
Expenses
ExpensesCr
322422201514111032917
Operating Profit
Operating ProfitCr
3353220-2-2-2-2-1
OPM
OPM%
8.511.417.514.310.411.71.5-24.9-305.0-24.0-9.4
Other Income
Other IncomeCr
011101100100
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
001111111000
PBT
PBTCr
2343120-3-2-2-2-2
Tax
TaxCr
111100000000
PAT
PATCr
2222110-3-2-2-2-2
Growth
PAT Growth%
8.135.516.3-1.9-64.125.7-137.4-518.114.810.816.4-1.3
NPM
NPM%
4.57.79.310.55.16.9-3.5-30.7-334.9-21.2-10.5
EPS
EPS
2.63.54.14.01.41.8-0.7-4.2-4.0-3.2-2.6-2.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
666666666666
Reserves
ReservesCr
571820192020196532
Current Liabilities
Current LiabilitiesCr
862423210157
Non Current Liabilities
Non Current LiabilitiesCr
011111110011
Total Liabilities
Total LiabilitiesCr
201928302830292613121415
Current Assets
Current AssetsCr
141312131416151210101111
Non Current Assets
Non Current AssetsCr
661617151414143234
Total Assets
Total AssetsCr
201928302830292613121415

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
2153230-1-86-6
Investing Cash Flow
Investing Cash FlowCr
-10-1-3200011-1
Financing Cash Flow
Financing Cash FlowCr
-1-1-1-1-1-100000
Net Cash Flow
Net Cash FlowCr
103-1330-1-87-7
Free Cash Flow
Free Cash FlowCr
1042230-1-86-7
CFO To PAT
CFO To PAT%
111.334.5206.3110.7264.5313.5-53.034.3381.3-311.1396.3
CFO To EBITDA
CFO To EBITDA%
59.023.2109.081.3129.8184.4127.342.2418.6-262.8350.1

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
14163834221116141359114
Price To Earnings
Price To Earnings
9.17.515.714.226.19.80.00.00.00.00.0
Price To Sales
Price To Sales
0.40.61.41.51.30.71.41.719.915.2
Price To Book
Price To Book
1.31.32.52.01.30.60.91.01.05.612.9
EV To EBITDA
EV To EBITDA
5.04.97.39.49.00.839.0-2.5-5.8-22.4-62.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.434.741.941.342.142.636.928.320.932.8
OPM
OPM%
8.511.417.514.310.411.71.5-24.9-305.0-24.0
NPM
NPM%
4.57.79.310.55.16.9-3.5-30.7-334.9-21.2
ROCE
ROCE%
18.024.615.212.34.95.9-1.5-10.8-16.7-18.0-18.1
ROE
ROE%
13.816.710.09.43.44.2-1.6-10.2-17.1-18.1-18.0
ROA
ROA%
7.811.18.87.93.13.6-1.4-9.5-16.8-16.1-11.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Daikaffil Chemicals India Limited is an Indian specialty chemicals manufacturer currently undergoing a strategic transformation. Following its acquisition in **2023-24**, the company has transitioned into a **step-down subsidiary of Heranba Industries Limited**, a major player in the agrochemical sector. Historically focused on **Optical Brightening Agents (OBA)** and **Dye Intermediates**, the company is now pivoting toward high-value research and global contract manufacturing. --- ### **Corporate Structure and Ownership Transition** The company recently underwent a formal change in control, integrating into the **Heranba Group** to diversify the parent group's chemical portfolio. * **Ultimate Holding Company:** **Heranba Industries Limited** (HIL). * **Direct Parent Company:** **Mikusu India Private Limited**, which acquired an initial **48.48%** stake in **January 2024** via a Share Purchase Agreement at **₹24 per share**. * **Regulatory Reclassification:** In **March 2025**, the BSE approved the reclassification of former promoters to the **'Public' category**, formalizing the Heranba Group’s leadership. * **Global Footprint:** In **August 2025**, the company incorporated **Mikusu Global Industries Limited** in **Nigeria** and approved a second subsidiary in the **UAE** to facilitate international expansion. --- ### **Specialized Product Portfolio and Market Applications** The company operates in the **Organic Dyes and Intermediaries** segment, utilizing **Japanese technology** to maintain a quality premium over regional competitors. | Product Category | Primary Function | Key End-Use Industries | | :--- | :--- | :--- | | **Optical Brighteners** | Fluorescent agents that absorb **UV light** and re-emit it in the **blue spectrum** to mask yellowing. | **Plastics, Fibers, Coatings, Inks, Detergents,** and **Uncoated Fine Paper**. | | **Naphthol Grounders** | Organic compounds used as a base for manufacturing **Organic Pigments** and **Masterbatches**. | **Paints, Printing Inks, Fabrics, Cosmetics,** and **Food Colorants**. | **Key Market Insights:** * **Optical Brighteners:** Essential for high-whiteness paper containing **High-Yield Pulp (HYP)** and for plastics requiring **high-temperature processing**. * **Naphthol:** Produced to **Japanese quality** standards; currently exported to MNCs in **Japan** and experiencing rapid demand growth in **Europe**. --- ### **Strategic Pivot: CRAMS, CRO, and CDMO** Under new leadership, Daikaffil is shifting from a niche manufacturer to a diversified service provider in the global life sciences supply chain. * **R&D Investment:** The company is establishing a world-class **Research and Development (R&D) centre** to enter the **Contract Research and Manufacturing Services (CRAMS)** and **CDMO** segments. * **Sector Targeting:** Strategy focuses on long-term partnerships with MNCs in the **agrochemical, pharmaceutical, biopharmaceutical, and specialty chemicals** sectors. * **Capacity Expansion:** Management is evaluating capacity increases for Naphthol grounders, contingent upon **Maharashtra Pollution Control Board (MPCB)** approvals. --- ### **Operational Status and Infrastructure** The company’s manufacturing operations have faced recent volatility, leading to a temporary shift in the business model. * **Manufacturing Facility:** Located at **Plot No. E-4, M.I.D.C. Tarapur, Boisar (Maharashtra)**. * **Operational Restart:** The facility underwent a **planned shutdown** in **November 2021** due to high fixed costs and low orders. Following the acquisition, the company withdrew its closure notice and is currently restoring manufacturing capacity as sales orders normalize. * **Interim Trading Strategy:** During the shutdown, the company sustained margins by **trading** in Dyes and Dye Intermediates. * **Real Estate Assets:** Holds freehold land at **Delisle Road, Mumbai** and residential property in **Navi Mumbai**. * **Accounting Alignment:** In **FY 2023-24**, the company transitioned its **Property, Plant and Equipment (PPE)** accounting from a **Revaluation model to a Cost model** to align with Heranba Industries Limited. --- ### **Financial Performance and Capital Structure** While the company has faced historical losses, recent projections indicate a sharp recovery in top-line growth. **Comparative Financial Summary:** | Metric | **FY 2024-25 (Proj/Curr)** | **FY 2023-24** | **FY 2022-23** | | :--- | :--- | :--- | :--- | | **Total Revenue** | **₹ 7.97 Crore** | **₹ 71.11 Lakh** | **₹ 1.05 Crore** | | **Loss After Tax (LAT)** | **₹ 1.59 Crore** | **₹ 1.90 Crore** | **₹ 2.13 Crore** | | **Sales Growth (Total)** | **100%** | **NIL** | **(92.19%)** | | **Cash & Equivalents** | **₹ 66.01 Lakh** | **₹ 7.52 Crore** | - | **Capital and Liquidity Management:** * **Authorized Capital:** Increased from **₹6.50 Crore** to **₹10.00 Crore** in **April 2025** to support expansion. * **Borrowing Limits:** Shareholders approved an increase in borrowing limits to **₹200 Crore** in **August 2024**. * **Related Party Framework:** A three-year **(2024-2027)** framework is in place for transactions with the Heranba Group, including **Inter-Corporate Deposits (ICDs)** and guarantees. --- ### **Risk Profile and Mitigation** The company operates under a board-approved risk management framework to address operational and macroeconomic headwinds. * **Going Concern Status:** Statutory auditors have noted **Material Uncertainty** regarding the company's ability to continue as a going concern, pending the full successful execution of the turnaround plan. * **Customer Concentration:** Historically, **95% of total sales** were attributed to a **single customer**, a risk the company is mitigating through global expansion in Nigeria and the UAE. * **Labor Relations:** Following a dispute with the **Shramik Utkarsh Sabha** union, a **Memorandum of Settlement** was reached on **February 22, 2024**. The company is now managing the reinstatement of workers. * **Market Risks:** * **Currency:** Exposure to **USD** and **Euro** is managed via **Forward Contracts** (up to **90 days**). * **Competition:** Intense pricing pressure from **Chinese and Indian manufacturers** is countered by a focus on **Japanese technology** and premium quality. * **Regulatory:** Expansion is strictly contingent upon environmental clearances and effluent discharge norms from the **MPCB**. --- ### **Leadership Team** The Board was reconstituted following the Heranba acquisition to align with the group's long-term vision: * **Mr. Sadashiv K. Shetty:** Non-Executive Chairman (Term ends **March 2029**). * **Mr. Raghuram K. Shetty:** Managing Director (Term ends **March 2029**). * **Internal Auditor:** **M/s SPSJ & Associates LLP** (Appointed **April 2024**).